This disclosure relates to novel morphinan compounds and their derivatives,
pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also …

This disclosure relates to novel morphinan compounds and their derivatives,
pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also …

The invention provides enantiopure deuterium-enriched bupropion, pharmaceutical
compositions, and methods of treating neurological disorders, movement disorders, cardio …

This disclosure relates to novel morphinan compounds and their derivatives,
pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also …

US8524780B2 - Deuterium-enriched bupropion - Google Patents US8524780B2 -
Deuterium-enriched bupropion - Google Patents Deuterium-enriched bupropion Download …

This invention relates to novel substituted pyridino nes, their derivatives, pharmaceutically
acceptable salts, Sol Vates, and hydrates thereof. This invention also provides com positions …

Accordingly, one object of the present invention is to pro vide deuterium-enriched bupropion
or a pharmaceutically acceptable salt thereof. It is another object of the present invention to …

This invention relates to novel compounds that are hydroxyethylamino Sulfonamide
derivatives and pharmaceu tically acceptable salts thereof. More specifically, this inven tion …

This invention relates to novel N-3-3-Fluoro-4-(4-mor pholinyl) phenyl-2-oxo-5-
oxazolidinylmethyl-acetamide derivatives, their acceptable acid addition salts, Solvates and …

5,886,026 A 3, 1999 Hunter et al. 6,099,562 A 8/2000 Ding et al. 6,221,335 B1 4/2001
Foster 6,440,710 B1 8/2002 Keinan et al. 6,603,008 B1 8, 2003 Ando et al. 6,803,031 B2 …